Watch BIVI. Know when insiders buy.
One email the day a filing lands. Free.
Work order
39
FLAG · insiders 77, shorts 0
Insiders, 90 days
+$49K
net buying · 4 buys, 0 sells · cluster
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $15.1MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$22.1MNET CASH $8.9M52W 0.96 – 2.28NEXT EARNINGS Nov 9 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2026 · Jun 30derived | — | — | — | −$5.7M | −$5.6M | — | -0.70 | −$4.1M | — | — | Aug 13 |
| Q3 2026 · Mar 31 | — | — | — | −$5.4M | −$5.3M | — | -0.70 | −$7.4M | — | — | May 11 |
| Q2 2026 · Dec 31 | — | — | — | −$6.3M | −$6.1M | — | -0.77 | −$4.4M | — | — | May 11 |
| Q1 2026 · Sep 30 | — | — | — | −$5.3M | −$5.1M | — | -0.98 | −$3M | — | — | May 11 |
| Q4 2025 · Jun 30derived | — | — | — | −$3.7M | −$3.5M | — | -1.44 | −$5.6M | — | — | Aug 13 |
| Q3 2025 · Mar 31 | — | — | — | −$3M | −$2.8M | — | -1.51 | −$1.3M | — | — | May 11 |
| Q2 2025 · Dec 31 | — | — | — | −$7.3M | −$7.1M | — | -4.55 | −$8.6M | — | — | May 11 |
| Q1 2025 · Sep 30 | — | — | — | −$4.1M | −$4.2M | — | -7.00 | −$3.6M | — | — | May 11 |
| Q4 2024 · Jun 30derived | — | — | — | −$4.8M | −$4.9M | — | -66.01 | −$4M | — | — | Aug 15 |
| Q3 2024 · Mar 31 | — | — | — | −$7.7M | −$8.1M | — | -2.00 | −$5.9M | — | — | May 12 |
| Q2 2024 · Dec 31 | — | — | — | −$8.8M | −$8.4M | — | -2.20 | −$5.9M | — | — | May 12 |
| Q1 2024 · Sep 30 | — | — | — | −$10.9M | −$10.7M | — | -2.92 | −$12.2M | — | — | May 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jun 30 | — | — | −$22.7M | −$22.1M | — | -3.05 | −$19M | — | — | — | — |
| FY2025 · to Jun 30 | — | — | −$18.1M | −$17.5M | — | -12.12 | −$19M | — | — | — | — |
| FY2024 · to Jun 30 | — | — | −$32.2M | −$32.1M | — | -73.05 | −$27.9M | — | — | — | — |
| FY2023 · to Jun 30 | — | — | −$45.1M | −$50.3M | — | -15.47 | −$40.3M | — | — | — | — |
| FY2022 · to Jun 30 | — | — | −$27.3M | −$26.1M | — | -1.06 | −$19M | — | — | — | — |
| FY2021 · to Jun 30 | — | — | −$138.1M | −$130.2M | — | -14.82 | −$10.5M | — | — | — | — |
Every number comes from BIOVIE INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.